ATYR Q1 2021 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$360,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$6M

Stockholders' Equity

$50M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$8M	-100.0%
Gross Profit	$0	$8M	-100.0%
Operating Income	-$7M	$2M	-487.4%
Net Income	-$7M	$2M	-507.9%